State of New Jersey Common Pension Fund D Sells 12,696 Shares of Avantor, Inc. (NYSE:AVTR)

State of New Jersey Common Pension Fund D decreased its holdings in Avantor, Inc. (NYSE:AVTR) by 4.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 247,458 shares of the company’s stock after selling 12,696 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Avantor were worth $6,402,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Swedbank AB acquired a new position in Avantor during the first quarter worth about $2,707,000. William Blair Investment Management LLC increased its position in Avantor by 44.6% during the 1st quarter. William Blair Investment Management LLC now owns 1,047,732 shares of the company’s stock worth $26,791,000 after purchasing an additional 322,985 shares in the last quarter. Sound Shore Management Inc. CT bought a new position in Avantor in the 2nd quarter valued at approximately $76,412,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Avantor by 18.5% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 353,687 shares of the company’s stock valued at $9,044,000 after buying an additional 55,129 shares in the last quarter. Finally, New York State Teachers Retirement System bought a new stake in shares of Avantor during the third quarter worth $8,473,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insiders Place Their Bets

In other news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at $740,372.64. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.50% of the company’s stock.

Avantor Stock Performance

Shares of AVTR opened at $22.30 on Tuesday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. Avantor, Inc. has a one year low of $18.41 and a one year high of $28.00. The stock has a 50-day moving average of $24.91 and a 200-day moving average of $24.10. The company has a market cap of $15.18 billion, a PE ratio of 48.48, a P/E/G ratio of 2.73 and a beta of 1.35.

Analysts Set New Price Targets

AVTR has been the subject of a number of research reports. Stifel Nicolaus raised their price objective on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, July 29th. Barclays cut their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. TD Cowen raised their price target on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Robert W. Baird reduced their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. Finally, Wells Fargo & Company lowered their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Avantor currently has a consensus rating of “Moderate Buy” and an average target price of $27.57.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.